← Back to Search

Essential Oil

Peppermint Oil for Interstitial Cystitis

Phase 1 & 2
Recruiting
Led By Sean Francis, MD
Research Sponsored by University of Louisville
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 8 weeks

Summary

This trial will study whether peppermint oil can help treat IC/BPS.

Eligible Conditions
  • Painful Bladder Syndrome

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~8 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 8 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
O'Leary/Sant questionnaire scores
Pelvic Pain and Urgency/Frequency questionnaire scores
Secondary study objectives
Additional IC/BPS Treatments received
Incidence of urinary tract infections (UTIs)
Urine pH

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Peppermint OilExperimental Treatment1 Intervention
Participants in the intervention (peppermint oil) arm will receive soft gels of enteric-coated peppermint oil (0.2mL=200mg). The enteric coated peppermint oil soft gel utilized in this study is Peptogest Peppermint Oil from Schwabe North America (Nature's Way Brand).
Group II: Coconut OilPlacebo Group1 Intervention
Participants in the placebo (coconut oil) arm will receive soft gels of enteric coated coconut oil. The enteric coated coconut oil soft gel utilized in this study is Coconut Oil from Schwabe North America (Nature's Way Brand).
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Peppermint oil
FDA approved

Find a Location

Logistics

Participation is compensated

You will be compensated for participating in this trial.

Who is running the clinical trial?

University of LouisvilleLead Sponsor
346 Previous Clinical Trials
77,465 Total Patients Enrolled
Integrative Therapeutics, Inc.Industry Sponsor
1 Previous Clinical Trials
257 Total Patients Enrolled
Sean Francis, MDPrincipal InvestigatorDepartment Chair

Media Library

Peppermint Oil (Essential Oil) Clinical Trial Eligibility Overview. Trial Name: NCT04845217 — Phase 1 & 2
Painful Bladder Syndrome Research Study Groups: Peppermint Oil, Coconut Oil
Painful Bladder Syndrome Clinical Trial 2023: Peppermint Oil Highlights & Side Effects. Trial Name: NCT04845217 — Phase 1 & 2
Peppermint Oil (Essential Oil) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04845217 — Phase 1 & 2
~24 spots leftby Nov 2025